CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L405. A total of 12 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $41,000 | -42.3% | 106,172 | 0.0% | 0.00% | – |
Q4 2019 | $71,000 | +69.0% | 106,172 | 0.0% | 0.00% | – |
Q3 2019 | $42,000 | -26.3% | 106,172 | 0.0% | 0.00% | – |
Q2 2019 | $57,000 | -46.7% | 106,172 | -7.0% | 0.00% | – |
Q1 2019 | $107,000 | +55.1% | 114,157 | +0.2% | 0.00% | – |
Q4 2018 | $69,000 | -86.6% | 113,964 | -69.8% | 0.00% | – |
Q3 2018 | $516,000 | -2.5% | 376,897 | +1.2% | 0.00% | – |
Q2 2018 | $529,000 | +4.5% | 372,497 | -0.4% | 0.00% | – |
Q1 2018 | $506,000 | -16.2% | 374,155 | +7.7% | 0.00% | – |
Q4 2017 | $604,000 | +27.7% | 347,446 | +34.5% | 0.00% | – |
Q3 2017 | $473,000 | +224.0% | 258,420 | +568.4% | 0.00% | – |
Q2 2017 | $146,000 | -70.9% | 38,665 | -73.6% | 0.00% | – |
Q1 2017 | $501,000 | +7.3% | 146,505 | +66.1% | 0.00% | – |
Q4 2016 | $467,000 | +66.2% | 88,191 | +88.1% | 0.00% | – |
Q3 2016 | $281,000 | -26.1% | 46,884 | -38.1% | 0.00% | – |
Q2 2016 | $380,000 | – | 75,786 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 559,900 | $2,111,000 | 0.75% |
WEDBUSH SECURITIES INC | 13,900 | $52,000 | 0.01% |
MinichMacGregor Wealth Management, LLC | 800 | $3,000 | 0.00% |
UBS Group AG | 180 | $1,000 | 0.00% |
D'Orazio & Associates, Inc. | 100 | $0 | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 30,913 | $117,000 | 0.00% |
Parallel Advisors, LLC | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 21,692 | $82,000 | 0.00% |
DEUTSCHE BANK AG\ | 2,403 | $9,000 | 0.00% |
PANAGORA ASSET MANAGEMENT INC | 10,346 | $39,000 | 0.00% |